Evidence map›Paper›PMID 35283831›Full record

ArticleFrontiers in microbiology2022

Antigen-Specific vs. Neutralizing Antibodies Against Conditioned Media of Patients With

Sophie Roth, Philipp Jung, James Boone, Alexander Mellmann, Anna Nimmesgern, Sören L Becker, Fabian K Berger, Lutz von Müller

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Toxins · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Sophie RothInstitute of Medical Microbiology and Hygiene, Saarland University, Homburg, Germany.
Philipp JungInstitute of Medical Microbiology and Hygiene, Saarland University, Homburg, Germany.
James BooneTechLab Research and Development, Blacksburg, VA, United States.
Alexander MellmannInstitute for Hygiene, University Hospital Münster, Münster, Germany.
Anna NimmesgernInstitute of Medical Microbiology and Hygiene, Saarland University, Homburg, Germany.
Sören L BeckerInstitute of Medical Microbiology and Hygiene, Saarland University, Homburg, Germany.
Fabian K BergerInstitute of Medical Microbiology and Hygiene, Saarland University, Homburg, Germany.
Lutz von MüllerGerman National Reference Center for Clostridioides difficile, Homburg, Germany.
Institute of Medical Microbiology and Hygiene · DESaarland University · DETechLab (United States) · USUniversity Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The immunological response against

Indexed as

antibodyClostridium difficilehumoral immune responsetreatmentvaccine

Identifiers

PMID35283831
PMCPMC8908241
OpenAlexW4213443135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.